FIG. 7.
Binding of hPIV-1 clinical isolates to gangliosides in solid-phase binding assays. The binding activities of hPIV-1 clinical isolates Cl-5, Cl-11, and Cl-14 were calculated as described in the legend to Fig. 2. Symbols: ●, NeuAcα2–3I; ○, NeuAcα2–6I; ▴, NeuAcα2–6SPG; ▵, GD1a; ▪, GM1a; □, GM3.